Your browser doesn't support javascript.
loading
Mechanistic modeling identifies drug-uptake history as predictor of tumor drug resistance and nano-carrier-mediated response.
Pascal, Jennifer; Ashley, Carlee E; Wang, Zhihui; Brocato, Terisse A; Butner, Joseph D; Carnes, Eric C; Koay, Eugene J; Brinker, C Jeffrey; Cristini, Vittorio.
Afiliação
  • Pascal J; Department of Pathology, The University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
  • Ashley CE; Biotechnology and Bioengineering Department, Sandia National Laboratories, Livermore, CA 94551-0969, USA.
  • Wang Z; Cancer Research and Treatment Center, The University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
  • Brocato TA; Department of Pathology, The University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
  • Butner JD; Department of Chemical and Nuclear Engineering, and Center for Biomedical Engineering, The University of New Mexico, Albuquerque, NM 87131, USA.
  • Carnes EC; Department of Chemical and Nuclear Engineering, and Center for Biomedical Engineering, The University of New Mexico, Albuquerque, NM 87131, USA.
  • Koay EJ; Nanobiology Department, Sandia National Laboratories, Albuquerque, CA 87185-1349.
  • Brinker CJ; Department of Chemical and Nuclear Engineering, and Center for Biomedical Engineering, The University of New Mexico, Albuquerque, NM 87131, USA.
  • Cristini V; Cancer Research and Treatment Center, The University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
ACS Nano ; 7(12): 11174-11182, 2013 Dec 23.
Article em En | MEDLINE | ID: mdl-24187963

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Carcinoma Hepatocelular / Nanomedicina / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ACS Nano Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Carcinoma Hepatocelular / Nanomedicina / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: ACS Nano Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Estados Unidos